Congress trades
Onconetix, Inc. (ONCO)
About Onconetix, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- David Allan White
- Employees
- 2
- Listed since
- Feb 18, 2022
- Market value
- $2.9M
- Price to earnings
- -
- Earnings per share
- -$4.55
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 12, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 13, 2026 | -$1.28 | -$4505.00 | $17K | $17K | EPS beatRevenue in line |
| Q1 FY2026reported May 13, 2026 | -$6.71 | n/a | $21K | n/a | EPS n/aRevenue n/a |
| Q4 FY2025reported Mar 12, 2026 | $12.58 | n/a | $304K | n/a | EPS n/aRevenue n/a |
| Q3 FY2025reported Nov 13, 2025 | -$31.25 | n/a | $304K | n/a | EPS n/aRevenue n/a |
| Q2 FY2025reported Aug 14, 2025 | -$2.02 | -$204.00 | $106K | n/a | EPS beatRevenue n/a |
| Q1 FY2025reported Jun 12, 2025 | $10.59 | -$348.50 | $102K | n/a | EPS beatRevenue n/a |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in ONCO
19 disclosures of 19 on record · median 24d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -99.5%S&P +14.9% · vs S&P 500 -114.4% | Oct 17, 2025 | Nov 10, 2025 | 24d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | n/a | Oct 11, 2023 | Nov 13, 2023 | 33d |
| Michael T. McCaul | Stock | Sale | $100,001 - $250,000 | n/a | Aug 24, 2023 | Sep 14, 2023 | 21d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | n/a | Jul 14, 2023 | Aug 16, 2023 | 33d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | n/a | Apr 18, 2023 | May 12, 2023 | 24d |
| Charles J. \'Chuck\' Fleischmann | Stock | Purchase | $1,001 - $15,000 | n/a | Apr 10, 2023 | May 9, 2023 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/a | Mar 14, 2023 | Apr 7, 2023 | 24d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | n/a | Jan 3, 2023 | Feb 15, 2023 | 43d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/a | Sep 29, 2022 | Oct 7, 2022 | 8d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/a | Jun 27, 2022 | Jul 7, 2022 | 10d |
| Ro Khanna | Bond | Sale | $15,001 - $50,000 | n/a | Jun 30, 2022 | Jul 7, 2022 | 7d |
| Diana Harshbarger | Stock | Purchase | $1,001 - $15,000 | n/a | May 16, 2022 | May 26, 2022 | 10d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | n/a | Jan 26, 2022 | Feb 23, 2022 | 28d |
| Michael T. McCaul | Bond | Purchase | $1,001 - $15,000 | n/a | Jan 22, 2019 | Feb 25, 2019 | 34d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | n/a | Oct 24, 2018 | Nov 15, 2018 | 22d |
| Michael T. McCaul | Bond | Purchase | $100,001 - $250,000 | n/a | Aug 28, 2018 | Sep 12, 2018 | 15d |
| Michael T. McCaul | Bond | Purchase | $100,001 - $250,000 | n/a | Sep 6, 2018 | Sep 12, 2018 | 6d |
| Michael T. McCaulFiled late | Stock | Sale | $1,001 - $15,000 | n/a | Dec 9, 2015 | Feb 3, 2016 | 56d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | n/a | Mar 6, 2014 | Apr 10, 2014 | 35d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 9, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded ONCO?
Michael T. McCaul, Charles J. \'Chuck\' Fleischmann, Ro Khanna, Diana Harshbarger disclosed ONCO transactions in the filings shown here.
How quickly are ONCO trades disclosed?
Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.